Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris La

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Environmental Science & Technology|December 6, 2022
Aerosol Oxidative Potential in the Greater Los Angeles Area: Source Apportionment and Associations with Socioeconomic PositionJiaqi Shen, Sina Taghvaee, Chris La, et al.
ACS Infectious Diseases|February 4, 2021
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl LinkerAhmed Abdelhameed, Mei Feng, April C Joice, et al.
Bioorganic & Medicinal Chemistry|September 17, 2024
N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitorsChris La Rosa, Pankaj Sharma, M Junaid Dar, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Environmental Science & Technology|December 6, 2022
Aerosol Oxidative Potential in the Greater Los Angeles Area: Source Apportionment and Associations with Socioeconomic PositionJiaqi Shen, Sina Taghvaee, Chris La, et al.
ACS Infectious Diseases|February 4, 2021
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl LinkerAhmed Abdelhameed, Mei Feng, April C Joice, et al.
Bioorganic & Medicinal Chemistry|September 17, 2024
N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitorsChris La Rosa, Pankaj Sharma, M Junaid Dar, et al.
Pageof 2